UBS Maintains a 'Neutral' on Forest Laboratories (FRX); An Aclidinium Approval As Expected
Tweet Send to a Friend
UBS maintains a 'Neutral' on Forest Laboratories (NYSE: FRX) price target of $35.00.
Last night, Forest Labs and Almirall ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Last night, Forest Labs and Almirall ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
